Drug neosensitization during anticonvulsant hypersensitivity syndrome

Journal of Investigational Allergology and Clinical Immunology

Volumn 16, Issue 5, 2006, Pages 321-326

  Gaig, P ^a   Garcia Ortega P ^b   Baltasar, M ^c   Bartra, J ^d  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c HOSPITAL VERGE DE LA CINTA   (Spain)

^d HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

Anticonvulsants; Carbamazepine; DRESS; Drug adverse reactions; Drug neosensitization; Phenytoin

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; CORTICOSTEROID; IBUPROFEN; PARACETAMOL; PHENYTOIN; TOBRAMYCIN; VALPROIC ACID; VIGABATRIN;

ADULT; AGED; ANGIONEUROTIC EDEMA; APHTHOUS ULCER; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; ENCEPHALITIS; EOSINOPHILIA; FEMALE; FEVER; HEPATITIS; HUMAN; HUMAN TISSUE; HYPOGAMMAGLOBULINEMIA; INTRACUTANEOUS TEST; LEUKOCYTOSIS; LYMPHADENOPATHY; MACULOPAPULAR RASH; MALE; NEPHRITIS; NEUTROPHILIA; PATCH TEST; PRICK TEST; PROTEINURIA; PRURITUS; PYELONEPHRITIS; RASH; TRIGEMINUS NEURALGIA; VASCULITIC RASH;

ADULT; AGED; ANTICONVULSANTS; CROSS REACTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; EXANTHEMA; FEMALE; HUMANS; MALE; MIDDLE AGED; SYNDROME;

EID: 33750053267     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Handfield-Jones SE, Jenkins RE, Whittaker SJ, Besse CP, McGibbon DH. The anticonvulsant hypersensitivity syndrome. Br Jr Dermatol. 1993;129:175-7.
2. Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention and management. Drug Safety. 1999;21:489-501.
3. Saltzstein SL, Ackerman LV. Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas. Cancer. 1959;12:164-82.
4. Kaur S, Sarkar R, Thami GP, Kanwar AJ. Anticonvulsant hypersensitivity syndrome. Pediatr Dermatol. 2002;19:142-5.
5. Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms). Semin Cutan Med Surg. 1996;15:250-7.
6. Haruda F. Phenytoin hypersensitivity: 38 cases. Neurology. 1979;29:1480-5.
7. Roujeau J, Stern R. Severe adverse cutaneous reactions to drugs. N Engl J Med. 1994;331:1272-85.
8. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest. 1988;82:1826-32.
9. Gennis MA, Vemuri R, Burns EA, Hill JV, Miller MA, Spielberg SP. Familial occurrence of hypersensitivity to phenytoin. Am J Med. 1991;91:631-4.
10. Okamoto Y, Shimizu K, Tamura K, Yamada M, Matsui Y, Hayakawa T, Mogami H. Effects of anticonvulsants on cellular immunity. No To Shinkei. 1989;41:299-304.
11. Pereira LF, Sanchez JF. Reversible panhypogammaglobulinemia associated with phenytoin treatment . Scand J Infect Dis. 2002;34:785-7.
12. Kano Y, Inaoka M, Shiohara T. Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia. Arch Dermatol. 2004;140: 183-8.
13. Descamps V, Valance A, Edlinger C , Filet AM, Grossin M, Lebrun-Vignes B, Belaich S, Crickx B. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137:301- 4.
14. Okada K, Sugiura T, Kuroda E, Tsuji S, Yamashita U. Phenytoin promotes Th2 type immune response in mice. Clin Exp Immunol. 2001;124:406-13.
15. Aihara M, Sugita Y, Takahashi S, Nagatani T, Arata S, Takeuchi K, Ikezawa Z. Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus. Br J Dermatol. 2001;144:1231-4.
16. Descamps V, Mahe E, Houhou N, Abramovitz L, Rozenberg F, Ranger-Rogez S, Crickx B. Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection. Br J Dermatol. 2003;148:1032-4.
17. Wong GAE, Shear NH. Is a drug alone sufficient to cause the drug hypersensitivity syndrome? Arch Dermatol. 2004;140:226-30.
18. Naisbitt DJ, Britschgi G, Wong G, Farrell J, Depta JPH, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol. 2003;63:732-41.
19. Pirmohamed M, Graham A, Roberts P, Smith D, Chadwick D, Breckenridge AM, Park BK. Carbamazepine-hypersensitivity: assessment of clinical and in vitro chemical cross reactivity with carbamazepine and oxcarbazepine. Br J Clin Pharmacol. 1991;32: 741-9.
20. Klassen BD, Sadler RM. Induction of hypersensitivity to a previously tolerated antiepileptic drug by a second antiepileptic drug. Epilepsia. 2001;42:433-5.
21. Galindo Bonilla PA, Romero Aguilera G, Feo Brito F, Gómez Torrijos E, García Rodríguez R, Cortina de la Calle P, Encinas Barrios C. Phenytoin hypersensitivity syndrome with positive patch test. A possible cross-reactivity with amitriptyline. J Invest Allergol Clin Immunol. 1998;8:186-90.
22. Aihara Y, Ito I, Aihara M, Yokota S. Two different adverse drug reactions in a pediatric patient separated by a 15-month interval: carbamazepine-induced hypersensitivity syndrome and cefaclor-induced cutaneous eruptions. Allergologie. 2004;27:163.
23. Pichler W, Yawalkar N, Schmid A, Helbling A. Pathogenesis of drug-related exanthems. Allergy. 2002;57:884-93.
24. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick DW, Pichler WJ, Pirmohamed M, Park BK. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol. 2003;111:1393-403.
25. Sullivan JR, Shear NH. The drug hypersensitivity syndrome. What is the pathogenesis? Arch Dermatol. 2001;137:357-63.